Obesity increases lymphedema risk for breast cancer survivors

Dec 18, 2008

Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health. Second only to the recurrence of cancer, it is the most dreaded effect of breast cancer treatment. In a new study, University of Missouri researchers found that the risk of developing lymphedema is 40 percent to 60 percent higher in women with body mass index (BMI) classified as overweight or obese compared to normal weight women. The researchers recommend increased health education for breast cancer survivors.

"Breast cancer survivors with high BMIs will benefit from education focused on maintaining optimal BMI and lymphedema risk reduction practices," said Jane Armer, professor in the Sinclair School of Nursing and director of nursing research at the Ellis Fischel Cancer Center. "Overweight women have the greatest risk of developing lymphedema and should be monitored closely for changes in symptoms and limb volume, especially those who have cancer treatment to the dominant side or experience post-operation swelling."

Based on the analysis, lymphedema is a risk for approximately two-thirds of breast cancer survivors in the 30 months after surgery. Breast cancer survivors who develop post-op swelling have a significantly higher risk (40 percent) of developing lymphedema. According to Armer, patients with high BMIs who experience post-op swelling or were affected by cancer on their dominant side have the highest risk of developing lymphedema. MU researchers found that comparing BMI and limb volume measurements can help clinicians better detect lymphedema.

"Diagnosing post-breast cancer lymphedema can be difficult because of inconsistent measurement approaches and standards of measurement reliability and validity," Armer said. "Pre-op limb volume measurement is an essential reference for post-op volume comparison and detection of post-op swelling. Clinicians should consider using a 5 percent limb volume change (LVC) approach (beyond change in BMI) as a more sensitive estimation of post-breast cancer lymphedema."

The study, "Post-Op Swelling and Lymphoedema Following Breast Cancer Treatment," was published in the Journal of Lymphoedema, Vol. 3, No. 2.

Source: University of Missouri-Columbia

Explore further: Endogenous hormones improve breast cancer risk models

add to favorites email to friend print save as pdf

Related Stories

Hormone-blocking drug reduces breast cancer risk

Jun 04, 2011

(AP) -- Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects ...

Recommended for you

Endogenous hormones improve breast cancer risk models

3 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

4 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 0